Prothena Corp. Plc (PRTA)
8.275
-0.08
(-1.02%)
USD |
NASDAQ |
Oct 05, 16:00
8.275
0.00 (0.00%)
After-Hours: 20:00
Prothena EPS Diluted (Quarterly) : -0.3564 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3564 |
| March 31, 2026 | 0.6047 |
| December 31, 2025 | -0.401 |
| September 30, 2025 | -0.6788 |
| June 30, 2025 | -2.336 |
| March 31, 2025 | -1.118 |
| December 31, 2024 | -1.077 |
| September 30, 2024 | -1.097 |
| June 30, 2024 | 1.215 |
| March 31, 2024 | -1.345 |
| December 31, 2023 | -1.257 |
| September 30, 2023 | 0.3777 |
| June 30, 2023 | -1.028 |
| March 31, 2023 | -0.8926 |
| December 31, 2022 | 0.1176 |
| September 30, 2022 | -0.974 |
| June 30, 2022 | -0.8812 |
| March 31, 2022 | -0.777 |
| December 31, 2021 | -0.7111 |
| September 30, 2021 | 2.134 |
| June 30, 2021 | 0.583 |
| March 31, 2021 | -0.9127 |
| December 31, 2020 | -0.7694 |
| September 30, 2020 | -0.766 |
| June 30, 2020 | -0.6585 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5906 |
| December 31, 2019 | -0.5402 |
| September 30, 2019 | -0.4875 |
| June 30, 2019 | -0.3965 |
| March 31, 2019 | -0.5234 |
| December 31, 2018 | -0.5634 |
| September 30, 2018 | -0.6163 |
| June 30, 2018 | -1.50 |
| March 31, 2018 | -1.26 |
| December 31, 2017 | -1.24 |
| September 30, 2017 | -1.37 |
| June 30, 2017 | -0.46 |
| March 31, 2017 | -0.99 |
| December 31, 2016 | -1.41 |
| September 30, 2016 | -1.26 |
| June 30, 2016 | -1.18 |
| March 31, 2016 | -0.81 |
| December 31, 2015 | -0.76 |
| September 30, 2015 | -0.73 |
| June 30, 2015 | -0.59 |
| March 31, 2015 | -0.55 |
| December 31, 2014 | -0.48 |
| September 30, 2014 | -0.48 |
| June 30, 2014 | 0.06 |
| March 31, 2014 | 0.78 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alkermes Plc | 0.0029 |
| Amarin Corp. Plc | -0.3681 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.58M |
| Revenue (Quarterly) | 1.01M |
| Total Expenses (Quarterly) | 19.59M |
| Enterprise Value | 151.38M |
| Gross Profit Margin (Quarterly) | 9.50% |
| Profit Margin (Quarterly) | -1.84K% |
| Earnings Yield | -10.05% |
| Normalized Earnings Yield | -10.72 |